Neuropsychopharmacology - Table of Contents alert Volume 38 Issue 3

TABLE OF CONTENTS Volume 38, Issue 3 (February 2013) In this issue Original Articles Correspondence Corrigendum Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Neuropsychopharmacology Reviews - Epigenetics The 2013 issue of Neuropsychopharmacology Reviews addresses epigenetics, the modification of genetic expression without changing the underlying DNA. Current research topics include therapeutic potential for neurological disorders and the effects of the maternal environment on the child's genetic expression. Read the issue here.   Original Articles Top Candidate Genes Expression Profile Associated with Antidepressants Response in the GENDEP Study: Differentiating between Baseline ‘Predictors’ and Longitudinal ‘Targets’ Open Annamaria Cattaneo, Massimo Gennarelli, Rudolf Uher, Gerome Breen, Anne Farmer, Katherine J Aitchison, Ian W Craig, Christoph Anacker, Patricia A Zunsztain, Peter McGuffin and Carmine M Pariante Neuropsychopharmacology 2013 38: 377-385; advance online publication, September 19, 2012; 10.1038/npp.2012.191 Abstract | Full Text Long-Lasting Increase of Corticosterone After Fear Memory Reactivation: Anxiolytic Effects and Network Activity Modulation in the Ventral Hippocampus Anne Albrecht, Gürsel Çalışkan, Melly S Oitzl, Uwe Heinemann and Oliver Stork Neuropsychopharmacology 2013 38: 386-394; advance online publication, September 12, 2012; 10.1038/npp.2012.192 Abstract | Full Text Interaction Between Behavioral and Pharmacological Treatment Strategies to Decrease Cocaine Choice in Rhesus Monkeys Matthew L Banks, Bruce E Blough and S Stevens Negus Neuropsychopharmacology 2013 38: 395-404; advance online publication, September 21, 2012; 10.1038/npp.2012.193 Abstract | Full Text A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of α4β2 Agonist ABT-894 in Adults with ADHD Earle E Bain, Weining Robieson, Yili Pritchett, Tushar Garimella, Walid Abi-Saab, George Apostol, James J McGough and Mario D Saltarelli Neuropsychopharmacology 2013 38: 405-413; advance online publication, October 3, 2012; 10.1038/npp.2012.194 Abstract | Full Text Interacting Effects of Naltrexone and OPRM1 and DAT1 Variation on the Neural Response to Alcohol Cues Joseph P Schacht, Raymond F Anton, Konstantin E Voronin, Patrick K Randall, Xingbao Li, Scott Henderson and Hugh Myrick Neuropsychopharmacology 2013 38: 414-422; advance online publication, October 3, 2012; 10.1038/npp.2012.195 Abstract | Full Text Disrupted-In-Schizophrenia-1 Gln31Leu Polymorphism Results in Social Anhedonia Associated with Monoaminergic Imbalance and Reduction of CREB and β-arrestin-1,2 in the Nucleus Accumbens in a Mouse Model of Depression Tatiana V Lipina, Paul J Fletcher, Frankie H Lee, Albert HC Wong and John C Roder Neuropsychopharmacology 2013 38: 423-436; advance online publication, September 26, 2012; 10.1038/npp.2012.197 Abstract | Full Text Striatal Adenosine Signaling Regulates EAAT2 and Astrocytic AQP4 Expression and Alcohol Drinking in Mice Moonnoh R Lee, Christina L Ruby, David J Hinton, Sun Choi, Chelsea A Adams, Na Young Kang and Doo-Sup Choi Neuropsychopharmacology 2013 38: 437-445; advance online publication, October 3, 2012; 10.1038/npp.2012.198 Abstract | Full Text A Role For The Prefrontal Cortex In Heroin-Seeking After Forced Abstinence By Adult Male Rats But Not Adolescents James M Doherty, Bradley M Cooke and Kyle J Frantz Neuropsychopharmacology 2013 38: 446-454; advance online publication, October 17, 2012; 10.1038/npp.2012.200 Abstract | Full Text Effects of Chronic Buspirone Treatment on Cocaine Self-Administration Nancy K Mello, Peter A Fivel, Stephen J Kohut and Jack Bergman Neuropsychopharmacology 2013 38: 455-467; advance online publication, October 17, 2012; 10.1038/npp.2012.202 Abstract | Full Text Bcl-2 rs956572 Polymorphism is Associated with Increased Anterior Cingulate Cortical Glutamate in Euthymic Bipolar I Disorder Márcio Gerhardt Soeiro-de-Souza, Giacomo Salvadore, Ricardo Alberto Moreno, Maria Concepción Garcia Otaduy, Kalil T Chaim, Wagner F Gattaz, Carlos A Zarate, Jr and Rodrigo Machado-Vieira Neuropsychopharmacology 2013 38: 468-475; advance online publication, October 17, 2012; 10.1038/npp.2012.203 Abstract | Full Text Effects of Short-Term Varenicline Administration on Emotional and Cognitive Processing in Healthy, Non-Smoking Adults: A Randomized, Double-Blind, Study Roel JT Mocking, C Patrick Pflanz, Abbie Pringle, Elizabeth Parsons, Sarah F McTavish, Phil J Cowen and Catherine J Harmer Neuropsychopharmacology 2013 38: 476-484; advance online publication, October 17, 2012; 10.1038/npp.2012.205 Abstract | Full Text Nature or Nurture? Determining the Heritability of Human Striatal Dopamine Function: an [18F]-DOPA PET Study Paul R A Stokes, Paul Shotbolt, Mitul A Mehta, Eric Turkheimer, Aaf Benecke, Caroline Copeland, Federico E Turkheimer, Anne R Lingford-Hughes and Oliver D Howes Neuropsychopharmacology 2013 38: 485-491; advance online publication, October 24, 2012; 10.1038/npp.2012.207 Abstract | Full Text Feasibility, Safety, and Efficacy of the Combination of D-Serine and Computerized Cognitive Retraining in Schizophrenia: An International Collaborative Pilot Study Deepak C D'Souza, Rajiv Radhakrishnan, Edward Perry, Savita Bhakta, Nagendra M Singh, Richa Yadav, Danielle Abi-Saab, Brian Pittman, Santosh K Chaturvedi, Mahendra P Sharma, Morris Bell and Chittaranjan Andrade Neuropsychopharmacology 2013 38: 492-503; advance online publication, October 24, 2012; 10.1038/npp.2012.208 Abstract | Full Text Glycine Transporter Type 1 Occupancy by Bitopertin: a Positron Emission Tomography Study in Healthy Volunteers Meret Martin-Facklam, Flavia Pizzagalli, Yun Zhou, Susanne Ostrowitzki, Vanessa Raymont, James R Brašić, Nikhat Parkar, Daniel Umbricht, Robert F Dannals, Ron Goldwater and Dean F Wong Neuropsychopharmacology 2013 38: 504-512; advance online publication, November 7, 2012; 10.1038/npp.2012.212 Abstract | Full Text Olanzapine Sensitization and Clozapine Tolerance: From Adolescence to Adulthood in the Conditioned Avoidance Response Model Jing Qiao, Hong Li and Ming Li Neuropsychopharmacology 2013 38: 513-524; advance online publication, November 7, 2012; 10.1038/npp.2012.213 Abstract | Full Text Effects of the BDNF Val66Met Polymorphism on White Matter Microstructure in Healthy Adults Heike Tost, Tajvar Alam, Matthew Geramita, Christine Rebsch, Bhaskar Kolachana, Dwight Dickinson, Beth A Verchinski, Herve Lemaitre, Alan S Barnett, Joey W Trampush, Daniel R Weinberger and Stefano Marenco Neuropsychopharmacology 2013 38: 525-532; advance online publication, November 7, 2012; 10.1038/npp.2012.214 Abstract | Full Text Convergent Findings for Abnormalities of the NF-κB Signaling Pathway in Schizophrenia Panos Roussos, Pavel Katsel, Kenneth L Davis, Stella G Giakoumaki, Larry J Siever, Panos Bitsios and Vahram Haroutunian Neuropsychopharmacology 2013 38: 533-539; advance online publication, November 7, 2012; 10.1038/npp.2012.215 Abstract | Full Text Correspondence Top Working Mechanism Underlying the Reduction of the Behavioral and Accumbal Dopamine Response to Cocaine by α-1-Adrenoceptor Antagonists Michel MM Verheij, Tadashi Saigusa, Noriaki Koshikawa and Alexander R Cools Neuropsychopharmacology 2013 38: 540-541; 10.1038/npp.2012.209 Full Text Corrigendum Top Loss of Environmental Enrichment Increases Vulnerability to Cocaine Addiction Joëlle Nader, Chauvet Claudia, Rana El Rawas, Laure Favot, Mohamed Jaber, Nathalie Thiriet and Marcello Solinas Neuropsychopharmacology 2013 38: 542; 10.1038/npp.2012.228 Full Text Advertisement Accepted Article Preview – Latest accepted manuscripts for publication in Neuropsychopharmacology. A non-typeset version of each new paper is posted online within 72h of acceptance. This means that the abstract will be searchable in PubMed (and the research citable) earlier than ever. To read our AAP articles click here   Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Neuropsychopharmacology. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.